Key statistics
As of last trade, Disc Medicine Inc (IRON:NMQ) traded at 64.83, 110.35% above the 52 week low of 30.82 set on Apr 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 65.92 |
|---|---|
| High | 66.49 |
| Low | 64.02 |
| Bid | 64.60 |
| Offer | 65.02 |
| Previous close | 66.54 |
| Average volume | 790.25k |
|---|---|
| Shares outstanding | 38.16m |
| Free float | 33.85m |
| P/E (TTM) | -- |
| Market cap | 2.54bn USD |
| EPS (TTM) | -5.98 USD |
Data delayed at least 15 minutes, as of Mar 03 2026 19:43 GMT.
More ▼
- Disc Medicine Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Disc Medicine to Participate in Upcoming Investor Conferences
- Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
- Disc Medicine Appoints Lisa Amaya Price, MBA as Chief Human Resources Officer
- Disc Medicine Highlights Recent Achievements and Key Business Objectives and Milestones for 2026
- Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
- Disc Medicine Reports Third Quarter 2025 Financial Results and Provides Business Update
- Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
- Disc Medicine to Participate in Upcoming Investor Conferences
More ▼
